UnknownNot Applicable

Telemedicine-Based Virtual Reality Clinic for the Treatment of Phobias

United States30 participantsStarted 2023-10-03

Plain-language summary

The purpose of this study is to assess the feasibility of conducting a randomized controlled efficacy trial comparing the delivery of exposure therapy via a telemedicine-based virtual reality clinic (Doxy.me VR) vs. standard telemental health (TMH) to adults with intense fear of dogs, snakes, and/or spiders. The secondary purpose is to preliminarily examine the efficacy of using Doxy.me VR vs. TMH in reducing phobia severity.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Is an adult ≥ 18 years old
✓. Has a self-reported fear of dogs, snakes, and/or spiders
✓. Indicates Subthreshold or Present Specific Phobia symptoms as determined by the study therapist via administration of the Diagnostic Assessment Research Tool (DART) Specific Phobia Module
✓. Has access to the internet AND a computer OR smartphone with video conferencing capabilities
✓. Will reside in the state of Florida for the duration of the study

Exclusion criteria

✕. Is participating in ongoing mental health therapy from a non-study therapist
✕. Has had changes to psychotropic medication use within six weeks preceding enrollment in the trial
✕. Reports active suicidal and/or homicidal intent or plan as determined by the study therapist via administration of the Diagnostic Assessment Research Tool (DART) Risk Assessment Module
✕. Reports active auditory, visual, and/or tactile hallucinations via the Diagnostic Assessment Research Tool (DART) Psychosis Module screening question
✕. Reports a history of epilepsy or seizures

What they're measuring

Phobia symptom severity

Timeframe: 3 Month Follow-Up

Trial details

NCT IDNCT06302868

SponsorUniversity of South Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-01

Contact for this trial

Kaitlyn R Schuler, PhD

813-396-9169 krschuler@usf.edu

View on ClinicalTrials.gov More Arachnophobia trials